IE45965B1 - P-biphenylyl estern of 15-heteroaryl-16,17,18,19,20,-petanorprostaglandins - Google Patents

P-biphenylyl estern of 15-heteroaryl-16,17,18,19,20,-petanorprostaglandins

Info

Publication number
IE45965B1
IE45965B1 IE1784/77A IE178477A IE45965B1 IE 45965 B1 IE45965 B1 IE 45965B1 IE 1784/77 A IE1784/77 A IE 1784/77A IE 178477 A IE178477 A IE 178477A IE 45965 B1 IE45965 B1 IE 45965B1
Authority
IE
Ireland
Prior art keywords
pentanor
biphenylyl
acid
compound
trans
Prior art date
Application number
IE1784/77A
Other languages
English (en)
Other versions
IE45965L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE45965L publication Critical patent/IE45965L/xx
Publication of IE45965B1 publication Critical patent/IE45965B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
IE1784/77A 1976-08-27 1977-08-26 P-biphenylyl estern of 15-heteroaryl-16,17,18,19,20,-petanorprostaglandins IE45965B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71813876A 1976-08-27 1976-08-27

Publications (2)

Publication Number Publication Date
IE45965L IE45965L (en) 1978-02-27
IE45965B1 true IE45965B1 (en) 1983-01-12

Family

ID=24884966

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1784/77A IE45965B1 (en) 1976-08-27 1977-08-26 P-biphenylyl estern of 15-heteroaryl-16,17,18,19,20,-petanorprostaglandins

Country Status (9)

Country Link
JP (1) JPS5328160A (da)
BE (1) BE858146A (da)
DE (1) DE2737807A1 (da)
DK (1) DK379277A (da)
FR (1) FR2362848A1 (da)
GB (1) GB1545411A (da)
IE (1) IE45965B1 (da)
LU (1) LU78021A1 (da)
NL (1) NL7709386A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204816A1 (es) * 1972-11-08 1976-03-05 Pfizer Procedimiento para preparar una prostaglandina
GB1482010A (en) * 1974-10-28 1977-08-03 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
IE45965L (en) 1978-02-27
NL7709386A (nl) 1978-03-01
BE858146A (fr) 1978-02-27
LU78021A1 (fr) 1979-05-23
FR2362848A1 (fr) 1978-03-24
FR2362848B1 (da) 1980-07-11
JPS5328160A (en) 1978-03-16
DK379277A (da) 1978-02-28
GB1545411A (en) 1979-05-10
DE2737807A1 (de) 1978-03-09

Similar Documents

Publication Publication Date Title
US4087604A (en) Substituted ω-pentanorprostaglandins
US4304907A (en) Bicyclo lactone intermediates for prostaglandin analogs
US3962293A (en) 13,14-Dihydro-16-fluoro prostaglandin F1
CH628028A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
DE2423155A1 (de) 5-oxa-prostaglandine und verfahren zu deren herstellung
DK144247B (da) 16-phenoxy-omega-tetranorprostaglandiner af e-eller f-raekken til anvendelse som fertilitetskontrolmidler
US4157341A (en) 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins
US3984400A (en) 11-Desoxy-16-aryl-ω-tetranorprostaglandins
USRE29926E (en) 2-Decarboxy-2-hydroxy-methyl-16-fluoro-PGE1 compounds
US4004020A (en) Novel prostanoic acid derivatives and process for the preparation thereof
IE46257B1 (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanorprostaglandins
US3984424A (en) P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
IE45965B1 (en) P-biphenylyl estern of 15-heteroaryl-16,17,18,19,20,-petanorprostaglandins
CH642063A5 (de) Verfahren zur herstellung von prostaglandin-analoga, bei welchen die carbonylgruppe am c-9 durch eine methylengruppe ersetzt ist.
US3892795A (en) 16-Methyl and 16,16 dimethyl PGA{HD 2 {B compounds
US4065472A (en) 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins
US3980642A (en) 15-Substitute D-ω-pentanorprostaglandins
US3903131A (en) 16 and 16,16-dimethyl PGE{HD 2{B
US4365077A (en) 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins
US4091207A (en) Prostaglandin intermediate including oxathio heterocyclic ring
US4036832A (en) 15-Substituted-ω-pentanorprostaglandins
US3954833A (en) 16,16-Methyl and ethyl substituted PGF2.sub.α compounds
US4455421A (en) 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins
US4244887A (en) Substituted ω-pentanorprostaglandins
US4212811A (en) Bicyclic lactone intermediates